US
Urmi Saha
About Urmi Saha
Data last updated:
Urmi Saha is a Whole-Time Director at Phylax Pharmaceuticals Private Limited (since 2012) and Director at Sushrusha Diagnostics Private Limited (since 2020). The companies operate in Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹1.43 Cr; the largest is Phylax Pharmaceuticals Private Limited at ₹1.41 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Phylax Pharmaceuticals Private Limited U24100WB2012PTC181438 | Whole-Time Director | 07 May 2012 | 2012 | ₹1.41 Cr (FY 2025) | Active |
| Sushrusha Diagnostics Private Limited U85110WB2020PTC239481 | Director | 05 Sep 2020 | 2020 | ₹2.2 Lakh (FY 2022) | Active |
Board colleagues of Urmi Saha
| Name | DIN | Company | Designation |
|---|---|---|---|
| Deba Prasad Saha | 05224664 | Phylax Pharmaceuticals Private Limited , Sushrusha Diagnostics Private Limited | Director |
| Satya Prasad Saha | 05224612 | Phylax Pharmaceuticals Private Limited , Sushrusha Diagnostics Private Limited | Whole-Time Director |
| Suvadra Urmila Saha | 08019377 | Phylax Pharmaceuticals Private Limited , Sushrusha Diagnostics Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Urmi Saha
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Urmi Saha
Urmi Saha currently holds 2 directorships: Phylax Pharmaceuticals Private Limited (Whole-Time Director, since 07 May 2012, revenue ₹1.41 Cr (FY 2025)); Sushrusha Diagnostics Private Limited (Director, since 05 Sep 2020, revenue ₹2.2 Lakh (FY 2022)).
Urmi Saha was first appointed on 07 May 2012 as Whole-Time Director at Phylax Pharmaceuticals Private Limited. The most recent appointment on record is 05 Sep 2020 at Sushrusha Diagnostics Private Limited.
The 2 current companies of Urmi Saha that report revenue have a combined latest revenue of ₹1.43 Cr: Phylax Pharmaceuticals Private Limited ₹1.41 Cr (FY 2025); Sushrusha Diagnostics Private Limited ₹2.2 Lakh (FY 2022).
The current boards of Urmi Saha's companies include Deba Prasad Saha (Phylax Pharmaceuticals Private Limited), Satya Prasad Saha (Phylax Pharmaceuticals Private Limited), Suvadra Urmila Saha (Phylax Pharmaceuticals Private Limited).